Bond rates: Why is RBI having a tough ride in keeping bond yields in check indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report
Prior to COVID-19 pandemic, India had been producing 60 percent of the world s vaccines for various diseases at an affordable rate.
COVID-19 vaccine (Representative image)
India has the capacity to produce vaccines not only for its own population but even for the other developing nations, and may emerge as the world s second largest COVID-19 vaccine maker, say analysts.
Prior to COVID-19 pandemic, India had been producing 60 percent of the world s vaccines for various diseases at an affordable rate, reported CNBC. India has been a manufacturing hub for vaccines … even before the pandemic, and should therefore be a strategic partner in the global inoculation against COVID-19, the business news site quoted JPMorgan analysts report published in January.
India has been a manufacturing hub for vaccines … even before the pandemic, and should therefore be a strategic partner in the global inoculation against COVID-19, JPMorgan analysts wrote in a report last month.
Consulting firm Deloitte predicts that India will be second only to the U.S. in terms of coronavirus vaccine production this year. PS Easwaran, a partner at Deloitte India, said more than 3.5 billion COVID vaccines could be made in the country in 2021, compared to around 4 billion in the U.S.
Furthermore, companies in India are currently scaling up production to meet demand. We are expanding our annualized capacities to deliver 700 million doses of our intramuscular COVAXIN, said Indian firm Bharat Biotech, which developed a COVID vaccine together with the state-run Indian Council of Medical Research.